KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Verisign (VRSN) Research & Development (2016 - 2026)

Verisign filings provide 18 years of Research & Development readings, the most recent being $27.5 million for Q1 2026.

  • Quarterly Research & Development rose 5.77% to $27.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $105.1 million through Mar 2026, up 7.35% year-over-year, with the annual reading at $103.6 million for FY2025, 7.14% up from the prior year.
  • Research & Development hit $27.5 million in Q1 2026 for Verisign, up from $26.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $27.5 million in Q1 2026 and bottomed at $20.3 million in Q2 2022.
  • Average Research & Development over 5 years is $23.8 million, with a median of $23.8 million recorded in 2024.
  • The largest annual shift saw Research & Development rose 12.81% in 2022 before it increased 2.48% in 2024.
  • Verisign's Research & Development stood at $21.5 million in 2022, then rose by 6.51% to $22.9 million in 2023, then increased by 8.73% to $24.9 million in 2024, then grew by 6.43% to $26.5 million in 2025, then rose by 3.77% to $27.5 million in 2026.
  • Per Business Quant, the three most recent readings for VRSN's Research & Development are $27.5 million (Q1 2026), $26.5 million (Q4 2025), and $25.4 million (Q3 2025).